Chagas disease: A report of 17 suspected cases in Japan, 2012-2017

Kazuo Imai, Kazuhisa Misawa, Morichika Osa, Norihito Tarumoto, Jun Sakai, Kei Mikita, Yusuke Sayama, Yuji Fujikura, Akihiko Kawana, Takashi Murakami, Shigefumi Maesaki, Sachio Miura, Takuya Maeda

Research output: Contribution to journalArticle

Abstract

Background: There are no reports on the prevalence of Chagas disease in Japan. Furthermore, screening programs and access to diagnosis and treatment have not been established. This study aimed to clarify the prevalence of Chagas disease among suspected cases in Japan and provide the reference data required for disease control. Methods: Seventeen patients with suspected Chagas disease in Japan between 2012 and 2017 were included in the study. Patients were diagnosed with Chagas disease based on the two different serological tests for antibodies to Trypanosoma cruzi. Real-Time polymerase chain reaction assay and blood culture techniques were performed to confirm T. cruzi parasitemia. Results: Of the 17 patients, 11 (64.7%) were immigrants from Latin America. Ultimately, 6 patients (35.3%) were diagnosed with Chagas disease. Of these 6 patients, median age was 53.5 years, 5 patients were immigrants from Latin American, and 1 was Japanese who had a congenital infection. T. cruzi parasitemia was confirmed in 4 patients (66.7%), and 5 (83.3%) were in the chronic phase (Chagas cardiomyopathy, 4; megacolon, 1). Two patients (33.3%) commenced benznidazole treatment. Conclusion: Our study showed that some patients of Chagas disease living in Japan are already in the chronic phase at diagnosis because of substantial diagnostic delays. Further epidemiological studies on the prevalence of Chagas disease and systematic screening programs for the Latin American population are needed.

Original languageEnglish
Article number38
JournalTropical Medicine and Health
Volume47
Issue number1
DOIs
Publication statusPublished - 2019 Jun 13

Fingerprint

Chagas Disease
Japan
Trypanosoma cruzi
Parasitemia
Chagas Cardiomyopathy
Megacolon
Culture Techniques
Latin America
Serologic Tests
Real-Time Polymerase Chain Reaction
Epidemiologic Studies
Antibodies
Therapeutics

Keywords

  • Cardiomyopathy
  • Chagas disease
  • Epidemiology
  • Immigrants
  • Japan

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Chagas disease : A report of 17 suspected cases in Japan, 2012-2017. / Imai, Kazuo; Misawa, Kazuhisa; Osa, Morichika; Tarumoto, Norihito; Sakai, Jun; Mikita, Kei; Sayama, Yusuke; Fujikura, Yuji; Kawana, Akihiko; Murakami, Takashi; Maesaki, Shigefumi; Miura, Sachio; Maeda, Takuya.

In: Tropical Medicine and Health, Vol. 47, No. 1, 38, 13.06.2019.

Research output: Contribution to journalArticle

Imai, K, Misawa, K, Osa, M, Tarumoto, N, Sakai, J, Mikita, K, Sayama, Y, Fujikura, Y, Kawana, A, Murakami, T, Maesaki, S, Miura, S & Maeda, T 2019, 'Chagas disease: A report of 17 suspected cases in Japan, 2012-2017', Tropical Medicine and Health, vol. 47, no. 1, 38. https://doi.org/10.1186/s41182-019-0168-3
Imai, Kazuo ; Misawa, Kazuhisa ; Osa, Morichika ; Tarumoto, Norihito ; Sakai, Jun ; Mikita, Kei ; Sayama, Yusuke ; Fujikura, Yuji ; Kawana, Akihiko ; Murakami, Takashi ; Maesaki, Shigefumi ; Miura, Sachio ; Maeda, Takuya. / Chagas disease : A report of 17 suspected cases in Japan, 2012-2017. In: Tropical Medicine and Health. 2019 ; Vol. 47, No. 1.
@article{e68caec17f144aeb87e762afa15c131d,
title = "Chagas disease: A report of 17 suspected cases in Japan, 2012-2017",
abstract = "Background: There are no reports on the prevalence of Chagas disease in Japan. Furthermore, screening programs and access to diagnosis and treatment have not been established. This study aimed to clarify the prevalence of Chagas disease among suspected cases in Japan and provide the reference data required for disease control. Methods: Seventeen patients with suspected Chagas disease in Japan between 2012 and 2017 were included in the study. Patients were diagnosed with Chagas disease based on the two different serological tests for antibodies to Trypanosoma cruzi. Real-Time polymerase chain reaction assay and blood culture techniques were performed to confirm T. cruzi parasitemia. Results: Of the 17 patients, 11 (64.7{\%}) were immigrants from Latin America. Ultimately, 6 patients (35.3{\%}) were diagnosed with Chagas disease. Of these 6 patients, median age was 53.5 years, 5 patients were immigrants from Latin American, and 1 was Japanese who had a congenital infection. T. cruzi parasitemia was confirmed in 4 patients (66.7{\%}), and 5 (83.3{\%}) were in the chronic phase (Chagas cardiomyopathy, 4; megacolon, 1). Two patients (33.3{\%}) commenced benznidazole treatment. Conclusion: Our study showed that some patients of Chagas disease living in Japan are already in the chronic phase at diagnosis because of substantial diagnostic delays. Further epidemiological studies on the prevalence of Chagas disease and systematic screening programs for the Latin American population are needed.",
keywords = "Cardiomyopathy, Chagas disease, Epidemiology, Immigrants, Japan",
author = "Kazuo Imai and Kazuhisa Misawa and Morichika Osa and Norihito Tarumoto and Jun Sakai and Kei Mikita and Yusuke Sayama and Yuji Fujikura and Akihiko Kawana and Takashi Murakami and Shigefumi Maesaki and Sachio Miura and Takuya Maeda",
year = "2019",
month = "6",
day = "13",
doi = "10.1186/s41182-019-0168-3",
language = "English",
volume = "47",
journal = "Tropical Medicine and Health",
issn = "1348-8945",
publisher = "Japanese Society of Tropical Medicine",
number = "1",

}

TY - JOUR

T1 - Chagas disease

T2 - A report of 17 suspected cases in Japan, 2012-2017

AU - Imai, Kazuo

AU - Misawa, Kazuhisa

AU - Osa, Morichika

AU - Tarumoto, Norihito

AU - Sakai, Jun

AU - Mikita, Kei

AU - Sayama, Yusuke

AU - Fujikura, Yuji

AU - Kawana, Akihiko

AU - Murakami, Takashi

AU - Maesaki, Shigefumi

AU - Miura, Sachio

AU - Maeda, Takuya

PY - 2019/6/13

Y1 - 2019/6/13

N2 - Background: There are no reports on the prevalence of Chagas disease in Japan. Furthermore, screening programs and access to diagnosis and treatment have not been established. This study aimed to clarify the prevalence of Chagas disease among suspected cases in Japan and provide the reference data required for disease control. Methods: Seventeen patients with suspected Chagas disease in Japan between 2012 and 2017 were included in the study. Patients were diagnosed with Chagas disease based on the two different serological tests for antibodies to Trypanosoma cruzi. Real-Time polymerase chain reaction assay and blood culture techniques were performed to confirm T. cruzi parasitemia. Results: Of the 17 patients, 11 (64.7%) were immigrants from Latin America. Ultimately, 6 patients (35.3%) were diagnosed with Chagas disease. Of these 6 patients, median age was 53.5 years, 5 patients were immigrants from Latin American, and 1 was Japanese who had a congenital infection. T. cruzi parasitemia was confirmed in 4 patients (66.7%), and 5 (83.3%) were in the chronic phase (Chagas cardiomyopathy, 4; megacolon, 1). Two patients (33.3%) commenced benznidazole treatment. Conclusion: Our study showed that some patients of Chagas disease living in Japan are already in the chronic phase at diagnosis because of substantial diagnostic delays. Further epidemiological studies on the prevalence of Chagas disease and systematic screening programs for the Latin American population are needed.

AB - Background: There are no reports on the prevalence of Chagas disease in Japan. Furthermore, screening programs and access to diagnosis and treatment have not been established. This study aimed to clarify the prevalence of Chagas disease among suspected cases in Japan and provide the reference data required for disease control. Methods: Seventeen patients with suspected Chagas disease in Japan between 2012 and 2017 were included in the study. Patients were diagnosed with Chagas disease based on the two different serological tests for antibodies to Trypanosoma cruzi. Real-Time polymerase chain reaction assay and blood culture techniques were performed to confirm T. cruzi parasitemia. Results: Of the 17 patients, 11 (64.7%) were immigrants from Latin America. Ultimately, 6 patients (35.3%) were diagnosed with Chagas disease. Of these 6 patients, median age was 53.5 years, 5 patients were immigrants from Latin American, and 1 was Japanese who had a congenital infection. T. cruzi parasitemia was confirmed in 4 patients (66.7%), and 5 (83.3%) were in the chronic phase (Chagas cardiomyopathy, 4; megacolon, 1). Two patients (33.3%) commenced benznidazole treatment. Conclusion: Our study showed that some patients of Chagas disease living in Japan are already in the chronic phase at diagnosis because of substantial diagnostic delays. Further epidemiological studies on the prevalence of Chagas disease and systematic screening programs for the Latin American population are needed.

KW - Cardiomyopathy

KW - Chagas disease

KW - Epidemiology

KW - Immigrants

KW - Japan

UR - http://www.scopus.com/inward/record.url?scp=85067315576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067315576&partnerID=8YFLogxK

U2 - 10.1186/s41182-019-0168-3

DO - 10.1186/s41182-019-0168-3

M3 - Article

AN - SCOPUS:85067315576

VL - 47

JO - Tropical Medicine and Health

JF - Tropical Medicine and Health

SN - 1348-8945

IS - 1

M1 - 38

ER -